Differences in cancer screening rates reported

September 18, 2003

Use of potentially life-saving cancer screening procedures among California adults varies dramatically depending on race and ethnicity, according to a new study by the UCLA Center for Health Policy Research.

The differences -- attributed to cultural, education, language and other barriers -- persist even when comparing like income levels or health insurance status across racial and ethnic groups. Lower screening rates reduce the odds of early detection for hundreds of thousands of Californians and survival rates for those who contract cancer.

The report was based on data from the 2001 California Health Interview Survey (CHIS 2001) and funded by The California Endowment. Researchers examined screening rates for cervical, breast, colorectal and prostate cancer among whites, Latinos, Asians, blacks, American Indian/Alaska Natives, and Native Hawaiian and other Pacific Islanders.

"Our findings underscore the reality that racial and ethnic disparities in cancer screening and other important health services can be found even within similar socioeconomic groups, such as low-income families and Medi-Cal beneficiaries," said author Ninez A. Ponce, a center researcher and assistant professor of health services at the UCLA School of Public Health, and a member of the Jonsson Comprehensive Cancer Center at UCLA.

"Clearly, targeting investment wisely toward the specific racial and ethnic groups most at risk remains a necessary step to save lives in California and reduce the burden of late-stage cancer care on the state's health care system," said author Susan H. Babey, a researcher at the UCLA Center for Health Policy Research.

"Improving the health of California's diverse communities is dependent on this critical information that helps identify the gaps that exist in health care and provides health leaders and community organizations with the information to improve access to preventive care for ethnic and racial minorities," said Alicia Lara, vice president of program for the endowment.

Screening saves lives by detecting cancer or pre-malignancies at a time when treatment typically is most successful. Five-year relative survival rates for breast, prostate, colorectal and cervical cancer rise above 90 percent if the tumor is discovered before it spreads to other parts of the body. Once a tumor is metastasized, survival rates drop to 34 percent for prostate cancer, 23 percent for breast cancer, 15 percent for cervical cancer and 9 percent for colorectal cancer.

The report includes detailed screening rates for the four cancers by 1) race/ethnicity alone, 2) income and race/ethnicity, and 3) Medi-Cal coverage and race/ethnicity. Among key findings in the report:The UCLA research team focused on the use of cancer screening tests among adults who have not been diagnosed with the site-specific cancer: Pap testing for cervical cancer; mammography for breast cancer; fecal occult blood test, colonoscopy or sigmoidoscopy for colorectal cancer; and the PSA (prostate specific antigen) test for prostate cancer.

Other report authors are E. Richard Brown, director of the UCLA Center for Health Policy Research and professor of public health; Neetu Chawla, a center researcher; David A. Etzioni of the David Geffen School of Medicine at UCLA; and Benjamin A. Spencer of the Greater Los Angeles VA Healthcare System.

CHIS 2001 data were compiled from interviews of more than 55,000 randomly selected adults drawn from every county in California. A collaboration of the UCLA Center for Health Policy Research, the California Department of Health Services and the Public Health Institute, this biennial survey is the largest of its kind conducted in any state and one of the largest in the nation.

In addition to releasing the report on cancer screening in California, the Center for Health Policy Research announced Sept. 18 the launch of CHIS 2003, funded in part by a $3.9 million grant from The California Endowment and through major support from the California Department of Health Services, the National Cancer Institute and the Robert Wood Johnson Foundation.
The UCLA Center for Health Policy Research, established in 1994, is one of the nation's leading health policy research centers and the premier source of key health-policy information for California. It is based in the UCLA School of Public Health and is also affiliated with the UCLA School of Public Policy and Social Research.

The Woodland Hills, Calif.-based California Endowment is a nonprofit organization dedicated to expanding access to affordable, quality health care for underserved individuals and communities, and to promote fundamental improvements in the health status of all Californians.

Online resources:

  • UCLA Center for Health Policy Research: www.healthpolicy.ucla.edu/
  • The California Endowment: www.calendow.org/
  • UCLA School of Public Health: www.ph.ucla.edu/
  • UCLA School of Public Policy and Social Research: www.sppsr.ucla.edu/
  • National Cancer Institute: www.nci.nih.gov/cancer_information/

    University of California - Los Angeles

    Related Breast Cancer Articles from Brightsurf:

    Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
    The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

    Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
    New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

    Partial breast irradiation effective treatment option for low-risk breast cancer
    Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

    Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
    Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

    More clues revealed in link between normal breast changes and invasive breast cancer
    A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

    Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
    A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

    Computers equal radiologists in assessing breast density and associated breast cancer risk
    Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

    Blood test can effectively rule out breast cancer, regardless of breast density
    A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

    Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
    Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

    Young breast cancer patients undergoing breast conserving surgery see improved prognosis
    A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

    Read More: Breast Cancer News and Breast Cancer Current Events
  • Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.